Sandoz, Inc. /
Coherus Ophthalmology LLC
Sandoz takes ownership of Coherus Ophthalmology LLC in CIMERLI divestiture
What happened
Coherus BioSciences, Inc. completed the sale of its subsidiary Coherus Ophthalmology LLC to Sandoz, Inc. The transaction included the CIMERLI ophthalmology franchise, sales teams and related assets.
Consideration was $170.0 million plus an additional $17.8 million for product inventory and prepaid manufacturing assets.
The source
Everything on this page comes from the source below.
Sandoz takes ownership of Coherus Ophthalmology LLC in CIMERLI divestiture
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly